Trials / Completed

CompletedNCT00377546

Comparison of Vitreous Levels of Acular LS 0.04%, Xibrom 0.09%, and Nevanac 0.1%

Status: Completed
Phase: Phase 4
Study type: Interventional
Enrollment: —

Sponsor: Innovative Medical · Industry
Sex: All
Age: —
Healthy volunteers: —

Summary

To compare the penetration of three different NSAIDs.

Conditions

Vitrectomy

Interventions

Type	Name	Description
DRUG	Nepafenac
DRUG	Ketorolac LS, Bromfenac

Timeline

First posted: 2006-09-18
Last updated: 2008-09-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00377546. Inclusion in this directory is not an endorsement.